Stop & Shop
Category Analyst Ii
Stop & Shop Sep 2015 - May 2019
Store Manager
Italian Social Club Sep 2015 - May 2019
Past President
Italian Social Club Jan 2014 - Dec 2017
President
Stop & Shop Nov 2008 - Sep 2015
Assistant Manager
Education:
University of Massachusetts Dartmouth 1998 - 2002
Bachelors, Marketing
Coyle & Cassidy High School 1994 - 1998
Skills:
Management Retail Leadership Microsoft Excel Merchandising Microsoft Word Inventory Management Time Management Customer Service
University Of Utah Obstetrics & Gynecology 50 N Medical Dr, Salt Lake City, UT 84132 8015817647 (phone)
Intermountain Medical GroupMckay-Dee Hospital Center For Maternal Fetal Medicine 4401 Harrison Blvd STE 4600, Ogden, UT 84403 8013874647 (phone), 8013874657 (fax)
University Hospital Maternal Fetal Medicine 50 N Medical Dr, Salt Lake City, UT 84132 8015818425 (phone), 8015852594 (fax)
Education:
Medical School University of Utah School of Medicine Graduated: 1992
Procedures:
Cesarean Section (C-Section) Vaginal Delivery
Conditions:
Complicating Pregnancy or Childbirth Conditions of Pregnancy and Delivery Pregnancy-Induced Hypertension Uncomplicated or Low Risk Pregnancy and Delivery Abnormal Vaginal Bleeding
Languages:
English Spanish
Description:
Dr. Draper graduated from the University of Utah School of Medicine in 1992. He works in Ogden, UT and 2 other locations and specializes in Obstetrics & Gynecology. Dr. Draper is affiliated with Intermountain McKay-Dee Hospital Center, Logan Regional Hospital and University Of Utah Hospital.
Joel Berniac - Stoneham MA, US Todd Bowser - Charlton MA, US Michael Draper - Plaistow NH, US Stuart B. Levy - Boston MA, US Mark L. Nelson - Norfolk MA, US
Assignee:
Paratek Pharmaceuticals, Inc. - Boston MA
International Classification:
A61K 31/835 A61K 31/16
US Classification:
514152, 5142315, 514616
Abstract:
Methods for using tetracycline compounds for the treatment of spinal muscular atrophy are described.
Methods Of Using Substituted Tetracycline Compounds To Modulate Rna
Joel Berniac - Stoneham MA, US Todd Bowser - Charlton MA, US Michael P. Draper - Windham NH, US Stuart B. Levy - Boston MA, US Mark L. Nelson - Norfolk MA, US
Assignee:
Paratek Pharmaceuticals, Inc. - Boston MA
International Classification:
A61K 31/835 A61K 31/16
US Classification:
514152, 5142315, 514616
Abstract:
Methods for using tetracycline compounds for the treatment of spinal muscular atrophy are described.
Substituted Tetracycline Compounds For Treatment Of Inflammatory Skin Disorders
Haregewein Assefa - Braintree MA, US Beena Bhatia - Mansfield MA, US Michael P. Draper - Windham NH, US Laura Honeyman - London, CA Oak Kim - Cambridge MA, US Dennis P. Molnar - Hopkinton MA, US
Assignee:
Paratek Pharmaceuticals, Inc. - Boston MA
International Classification:
A61K 31/65 C07C 237/26
US Classification:
514152, 552204
Abstract:
Methods and compositions for the treatment of skin disorders (e. g. , acne, rosacea) are described.
Tetracycline Compounds Having Target Therapeutic Activities
The present invention relates to substituted tetracycline compounds and related methods for increasing the antifungal activity of an antifungal agent. The methods include administering to a subject an effective amount of a substituted tetracycline compound in combination with an antifungal agent such that the subject is treated for the fungal associated disorder.
Substitutedtetracycline Compounds For The Treatment Of Malaria
Michael DRAPER - Windham NH, US Mark L. NELSON - Norfolk MA, US
Assignee:
Paratek Pharmaceuticals, Inc. - Boston MA
International Classification:
A61K 31/65 A61P 33/06
US Classification:
514154, 514152
Abstract:
This invention provides a method for treating or preventing malaria in a subject. The method includes administering to the subject an effective amount of a substituted tetracycline compound, such that malaria is treated or prevented. In one aspect, the invention relates to pharmaceutical compositions which include an effective amount of a tetracycline compound to treat malaria in a subject and a pharmaceutically acceptable carrier. The substituted tetracycline compounds of the invention can be used to in combination with one or more anti-malarial compounds or can be used to treat or prevent malaria which is resistant to one or more other anti-malarial compounds.